Evidence map›Paper›PMID 20037137›Full record

ArticleAJNR. American journal of neuroradiology2010

Pitfalls in the use of voxel-based morphometry as a biomarker: examples from huntington disease.

S M D Henley, G R Ridgway, R I Scahill, S Klöppel, S J Tabrizi, N C Fox, J Kassubek, EHDN Imaging Working Group

2 registry-linked trialsAbstract read
In one paragraph

Article in AJNR. American journal of neuroradiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 52 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01590589 completednot on this map

REGISTRY - an Observational Study of the European Huntington's Disease Network (EHDN)

TypeobservationalSponsorEuropean Huntington's Disease NetworkRan2004 to 2017Enrolled10,000ConditionsHuntington Disease, Huntington's Disease
NCT01590602 completednot on this mapstarted 2011, after this paper: background citation

REGISTRY-JHD - an Observational Study of the European Huntington's Disease Network (EHDN)

TypeobservationalSponsorEuropean Huntington's Disease NetworkRan2011 to 2017Enrolled78ConditionsHuntington Disease, Juvenile
3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Cortical changes in the brain of patients with hemifacial spasm.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Relations of gray matter volume to dimensional measures of cognition and affect in mood disorders.Cortex; a journal devoted to the study of the nervous system and behavior · 2022
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

S M D HenleyDementia Research Centre, Department of Neurodegenerative Disease, Institute of Neurology, University College London, United Kingdom.
G R Ridgway
R I Scahill
S Klöppel
S J Tabrizi
N C Fox
J Kassubek
EHDN Imaging Working Group

Funding

Medical Research Council G0601846Medical Research Council G0801306
6 · The paper itself

Abstract

background and purposeVBM is increasingly used in the study of neurodegeneration, and recently there has been interest in its potential as a biomarker. However, although it is largely "automated," VBM is rarely implemented consistently across studies, and changing user-specified options can alter the results in a way similar to the very biologic differences under investigation. MATERIALS AND

methodsThis work uses data from patients with HD to demonstrate the effects of several user-specified VBM parameters and analyses: type and level of statistical correction, modulation, smoothing kernel size, adjustment for brain size, subgroup analysis, and software version.

resultsThe results demonstrate that changing these options can alter results in a way similar to the biologic differences under investigation.

conclusionsIf VBM is to be useful clinically or considered for use as a biomarker, there is a need for greater recognition of these issues and more uniformity in its application for the method to be both reproducible and valid.

Indexed as

AdultBiomarkersBrainFemaleGenetic Carrier ScreeningGenetic Predisposition to DiseaseHumansHuntington DiseaseImage Processing, Computer-AssistedLongitudinal StudiesMagnetic Resonance ImagingMaleMiddle AgedOrgan SizeReference ValuesSensitivity and SpecificityBiomarkers

Identifiers

PMID20037137
PMCPMC7964217

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.